Top Markets
Coin of the day
Amniotics AB (publ) Amniotics AB (publ)

Amniotics AB (publ)

AMNI
Ранг среди акций #37511
Amniotics AB (publ) specializes in the creation, manufacturing, and... Amniotics AB (publ) specializes in the creation, manufacturing, and commercialization of stem cell-based therapies, utilizing mesenchymal stem cells to address critical, life-threatening illnesses. The company's primary therapeutic candidate, PulmoStem, is designed for the treatment of inflammatory and fibrotic conditions affecting the lungs. Furthermore, Amniotics is advancing other promising treatments such as CogniStem for neurological disorders, NephroStem for kidney-specific ailments, and CutiStem for various dermatological issues. Beyond its own pipeline, the firm provides contract development and manufacturing services for advanced therapy medicinal products to pharmaceutical companies, universities, and hospitals. Established in 2015, Amniotics AB is headquartered in Lund, Sweden.
Цена акции
$0.00060315
Последняя синхронизация: 2024-09-27
Рыночная капитализация
$1.65M
Изменение (1 день)
19.64%
Изменение (1 год)
0.00%
Страна
SE
Торговля Amniotics AB (publ) (AMNI)

Категория

EPS для Amniotics AB (publ) (AMNI)
EPS по состоянию на December 2023 TTM: $-0.04
Согласно последним финансовым отчетам и цене акций Amniotics AB (publ), текущий EPS компании (TTM) составляет $-0.04. В конце 2022 EPS компании составлял $-0.03, меньше, чем показателю 2021 года, равному $-0.04.
История EPS компании Amniotics AB (publ) с 2018 по 2026
EPS на конец каждого года
Год EPS Изменить
2026 (TTM) $-0.04 -96.18%
2023 0.00 -96.18%
2022 $-0.03 -21.10%
2021 $-0.04 77.18%
2020 $-0.02 237.70%
2019 $-0.01 45.24%
2018 0.00 0.00%
EPS для аналогичных компаний или конкурентов
Компания EPS Разница в EPS Страна
$17.32 -47,293.46%
US
$27.74 -75,685.83%
NL
- -
CH
- -
KR
$13.70 -37,429.97%
BE